TELNIVOC-M FORTE
March 31, 2026
VOGIVOC-0.3
March 31, 2026
VOGIVOC-M
₹1,090.00
Composition:
Teneligliptin 20 mg & Metformin HCl 1000 mg
Packaging Detail:
10 x 10
Description
A combination tablet for type 2 diabetes containing Voglibose (an alpha-glucosidase inhibitor) and sustained-release Metformin. It works by delaying carbohydrate absorption and reducing hepatic glucose production.
Indications
Indications
-
Type 2 diabetes mellitus for postprandial blood sugar control.
-
As an adjunct to diet and exercise.
Side Effects
Side Effects
-
Flatulence, abdominal distension, and diarrhea (due to Voglibose).
-
Nausea and vomiting (due to Metformin).
-
Hypoglycemia (rare when used alone).
-
Rare risk of lactic acidosis.
Reviews 0
Reviews
There are no reviews yet.